コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 melanocyte-derived intermediate cells in the stria vascularis.
2 , forming the intermediate cell layer of the stria vascularis.
3 ner hair cells or a reduced thickness of the stria vascularis.
4 stemic circulation and the fluids inside the stria vascularis.
5 egions medial to inner HCs as well as in the stria vascularis.
6 e progressive appearance of large lesions in stria vascularis.
7 maintained in scala media, generated by the stria vascularis.
8 articular in the cochlear organ of Corti and stria vascularis.
9 nd structurally damaged blood vessels in the stria vascularis.
10 at Kir4.1 confers the outflow of K(+) in the stria vascularis.
11 endocochlear potential due to atrophy of the stria vascularis.
12 y regions between the sensory tissue and the stria vascularis.
13 in the potassium-secreting epithelium of the stria vascularis.
14 lt animals through rapid degeneration of the stria vascularis.
15 , spiral ganglia, the spiral limbus, and the stria vascularis.
16 lesions in the cochlea were found within the stria vascularis, a barrier epithelium containing the pr
17 s to spindle, root, and basal cells from the stria vascularis, a structure in the cochlea necessary f
18 In the previously reported S1pr2(-/-) mice, stria vascularis abnormalities, organ of Corti degenerat
19 cytes (intermediate cells) in the developing stria vascularis, all of which are significantly diminis
20 ts principally from degeneration of cochlear stria vascularis and decline of the endocochlear potenti
21 ortance of basal cell tight junctions in the stria vascularis and directly verify the two-cell hypoth
23 on by altering ion channel expression in the stria vascularis and inducing blood-labyrinth barrier (B
24 artery, which supplies blood directly to the stria vascularis and protects its capillary bed from hig
25 tissues, increased E2F1 and apoptosis in the stria vascularis and spiral ganglion neurons of the inne
27 tribution of nonsensory cell networks in the stria vascularis and the sensory region toward the matur
29 ing was restricted to the basal cells in the stria vascularis and was also detectable in the spiral g
30 an of Corti, in the basal cell region of the stria vascularis, and in type 1 fibrocytes of the spiral
31 We found that hair cells, marginal cells of stria vascularis, and other cells lining the cochlear an
32 was observed to leak from capillaries of the stria vascularis, and pericytes lost their tight associa
33 barrier properties of tight junctions of the stria vascularis appeared intact in a biotin tracer assa
34 in the human cochlea, and they point to the stria vascularis as an important therapeutic target for
35 licated apoptosis in the spiral ganglion and stria vascularis because of mitochondrial reactive oxyge
36 megalin, the candidate AG transporter in the stria vascularis, by binding competitor cilastatin preve
37 ments (organ of Corti, afferent neurons, and stria vascularis) can degenerate independently, and exer
39 either to cochlear sensory epithelial or to stria vascularis cells as the cell types most prominentl
40 paratus of renal glomerular podocytes and in stria vascularis cells of the inner ear, consistent with
41 we show that cochlear epithelial cells, not stria vascularis cells, are the main inner-ear cells rel
42 high throughput of K(+) across cells of the stria vascularis, conferred partly by the activity of Ki
44 berrations in outer and inner hair cells and stria vascularis defects, leading to deafness in the var
45 hepatocyte growth factor (HGF) signaling in stria vascularis development for the first time and that
46 ochlear potential, indicative of significant stria vascularis dysfunction, but without obvious signs
49 n of transcripts in the WT versus Nr3b2(-/-) stria vascularis has identified a set of genes that is l
52 Our findings indicate the importance of the stria vascularis in the mechanism of hearing impairment,
54 of the cochlea revealed degeneration of the stria vascularis, in conjunction with disorganization of
55 neural crest cells fail to migrate into the stria vascularis intermediate layer, resulting in a sign
56 n proteins in the endothelial barrier of the stria vascularis (intrastrial fluid-blood barrier) throu
59 ent increase in macrophage activation in the stria vascularis is associated with a decline in auditor
60 embranes in the cochlea, suggesting that the stria vascularis is the primary site of cochlear pathoge
62 ss structures of the endolymphatic space and stria vascularis observed at the light microscope level
63 acrophage-like melanocytes (PVM/Ms) from the stria vascularis of mice aged between P10 and P15 (P, po
64 anently impaired expression of KCNJ10 in the stria vascularis of Pit1(dw) mice, which likely contribu
65 rporation of the melanocytes into the future stria vascularis of the cochlear duct requires c-MET sig
67 ll barriers and the capillary bed within the stria vascularis of the S1P(2) receptor-null mice showed
69 y preserving the structural integrity of the stria vascularis.SIGNIFICANCE STATEMENT Mutations in Med
70 y outer hair cells (OHCs), inner hair cells, stria vascularis, spiral ganglia, and surrounding nerves
71 tivity to 8-isoprostane was increased in the stria vascularis, spiral ganglion cells and the organ of
72 vity delineated blood vessels located in the stria vascularis, spiral ligament, sub-basilar region, s
73 ing that the intermediate cells (ICs) of the stria vascularis (StV) express outward K+ current that r
75 early pathophysiological alterations in the stria vascularis (SV) are associated with increased macr
80 ar melanocytes are intermediate cells in the stria vascularis that generate endocochlear potentials r
81 ibration into electrical signals, versus the stria vascularis, the cellular battery that powers trans
82 tin accumulation is consistently high in the stria vascularis, the region of the cochlea that maintai
84 evealed that pericytes on capillaries of the stria vascularis were closely associated with the endoth
86 hin the organ of Corti, spiral ganglion, and stria vascularis, which are known targets of cisplatin o
87 ced by 4 and 8 weeks old in mutants, and the stria vascularis, which generates the EP, showed degener